Predicted protein targets (top 10)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.42 |
| ▸ | MEN1 | O00255 | 1/20 | 0.42 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.42 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.42 |
| ▸ | ABCC9 | O60706 | 7/20 | 0.40 |
| ▸ | ABCB1 | P08183 | 2/20 | 0.36 |
| ▸ | KCNA5 | P22460 | 1/20 | 0.35 |
| ▸ | CTSL | P07711 | 1/20 | 0.35 |
| ▸ | CTSS | P25774 | 1/20 | 0.35 |
| ▸ | CTSK | P43235 | 1/20 | 0.35 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL5664620 | 1.00 | ALDH1A1 (0.42) | ALDH1A1MEN1KMT2ASMN1; SMN2ABCC9 | |
| SCHEMBL13199544 | 0.86 | ABCB1 (0.41) | ALDH1A1MEN1KMT2ASMN1; SMN2ABCC9 | |
| SCHEMBL2880571 | 0.83 | KCNH2 (0.40) | ALDH1A1SMN1; SMN2ABCC9 | |
| SCHEMBL2880578 | 0.83 | KCNH2 (0.40) | ALDH1A1SMN1; SMN2ABCC9 | |
| SCHEMBL2883993 | 0.82 | KCNA5 (0.41) | ALDH1A1MEN1KMT2ASMN1; SMN2ABCB1 | |
| SCHEMBL13199547 | 0.81 | ALDH1A1 (0.40) | ALDH1A1MEN1KMT2ASMN1; SMN2 | |
| SCHEMBL2887357 | 0.81 | ABCC9 (0.42) | ABCC9ABCB1 | |
| SCHEMBL2887359 | 0.81 | ABCC9 (0.42) | ABCC9ABCB1 | |
| SCHEMBL2889523 | 0.81 | IDO1 (0.40) | ALDH1A1MEN1KMT2ASMN1; SMN2ABCC9 | |
| SCHEMBL2889524 | 0.81 | IDO1 (0.40) | ALDH1A1MEN1KMT2ASMN1; SMN2ABCC9 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20070299130-A1 | Benzopyran Compound | NISSAN CHEMICAL INDUSTRIES, LTD. (JP) | 2007-12-27 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20070299130-A1 | Benzopyran Compound | NR0B1, CYP2B6, RYR2 | ALDH1A1 2971/4885MEN1 3048/4885KMT2A 2949/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.